Studies of association between the obsessive-compulsive disorder and candidate genes: A review;Estudos de associação entre transtorno obsessivo-compulsivo e genes candidatos: Uma revisão

Jornal Brasileiro de Psiquiatria

Volumn 55, Issue 4, 2006, Pages 288-295

  Da Rocha, Felipe Filardi ^a,b,d   De Sousa, Karla Cristhina Alves ^a   Teixeira, Antônio Lúcio ^a   Fontenelle, Leonardo F ^c   Romano Silva, Marco Aurélio ^b   Corrêa, Humberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Instituto de Ciências Biológicas da UFMG ICB UFMG

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Faculdade de Medicina da Universidade Federal do Rio de Janeiro ^*  (Brazil)

Author keywords

Genes; Obsessive compulsive disorder; Polymorphism

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; SEROTONIN; SERTRALINE;

CLINICAL FEATURE; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; OBSESSIVE COMPULSIVE DISORDER; REVIEW; SEROTONINERGIC SYSTEM;

EID: 34548116761     PISSN: 00472085     EISSN: 19820208     Source Type: Journal    
DOI: 10.1590/S0047-20852006000400005     Document Type: Review

References (80)

1. Alsobrook JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet, 114: 116-20, 2002.
2. Altemus M, Murphy DL, Greenberg B, Lesch KP. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder Am J Med Genet, 67: 409-11, 1996.
3. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology, 174: 530-8, 2004.
4. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry, 63: 769-76, 2006.
5. Baca-Garcia E, Salgado BR, Segal HD, Lorenzo CV, Acosta MN, Romero MA, et al. A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism. Prog Neuropsychophar Biol Psychiatry, 29: 713-7, 2005.
6. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, et al. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry, 4: 463-6, 1999.
7. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL. Obsessive-compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry, 2: 403-6, 1997.
8. Billett EA, Richter MA, Sam F, Swinson RP, Dai XY, King N, et al. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr Genet, 8: 163-9, 1998.
9. Camarena B, Aguilar A, Loyzaga C, Nicolini H. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol, 7: 49-53, 2004.
10. Camarena B, Loyzaga C, Aquilar A, Weissbecker K, Nicolini H. Association study between the dopamine receptor D(4) gene and obsessive-compulsive disorder. Eur Neuropsychoph, 2006. Epub ahead of print.
11. Camarena B, Rinetti G, Cruz C, Gomez A, de La Fuente JR, Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet, 105: 279-82, 2001.
12. Camarena B, Rinetti G, Cruz C, Hernandez S, de la Fuente JR, Nicolini H. Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. Int J Neuropsychoph, 4: 269-72, 2001.
13. Carey G, Gottesman II. Twin and family studies of anxiety, phobic and obsessive disorders. In: Klien DF, Rabkin J, editors. Anxiety: new research and changing concepts. New York: Raven Press, 1981. p. 117-36.
14. Catalano M, Sciuto G, Di Bella D, Novelli E, Nobile M, Bellodi L. Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am J Med Genet, 54: 253-5, 1994.
15. Cavallini MC, Di Bella D, Pasquale L, Henin M, Bellodi L. 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res, 77: 97-104, 1998.
16. Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet, 114: 347-53, 2002.
17. Cavalini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive-compulsive disorder and related disorders. Am J Med Genet, 88: 38-43, 1999.
18. Chabane N, Millet B, Delorme R, Lichtermann D, Mathieu F, Laplanche JL, et al. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci Lett, 363: 154-6, 2004.
19. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry, 1: 453-60, 1996.
20. Cruz C, Camarena B, King N, Paez F, Sidenberg D, de la Fuente JR, et al. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci Lett, 231: 1-4, 1997.
21. Delorme R, Durand CM, Betancur C, Wagner M, Ruhrmann S, Grabe HJ, et al. No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biol Psychiatry, 60: 202-3, 2006.
22. Delorme R, Krebs MO, Chabane N, Roy I, Millet B, Mouren-Simeoni MC, et al. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive-compulsive disorder. Neuroreport, 15: 699-702, 2004.
23. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG. Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Dis, 91: 39-44, 2006.
24. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. Association between the dopamine D(2) receptor Taql A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychoph, 16: 446-50, 2006.
25. Di Bella D, Catalano M, Cichon S, Nothen MM. Association study of a null mutation in the dopamine D4 receptor gene in Italian patients with obsessive-compulsive disorder, bipolar mood disorder and schizophrenia. Psychiatr Genet, 6: 119-21, 1996.
26. Di Bella D, Cavallini MC, Bellodi L. No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am J Psychiatry, 159: 1783-5, 2002.
27. Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L. Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J, 2: 176-81, 2002.
28. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry, 63: 778-85, 2006.
29. Enoch MA, Greenberg BD, Murphy DL, Goldman D. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry, 49: 385-8, 2001.
30. Enoch MA, Kaye WH, Rotondo A, Greenberg BD, Murphy DL, Goldman D. 5-HT2A promoter polymorphism -1438G/A, anorexia nervous, and obsessive-compulsive disorder. Lancet, 351: 1785-6, 1998.
31. Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, et al. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety, 18: 41-5, 2003.
32. Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, et al. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychoph, 10: 205-9, 2000.
33. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry, 160: 636-45, 2003.
34. Gottesman II, Hanson DR. Human development: biological and genetic processes. Annu Rev Psychol, 56: 263-86, 2005.
35. Graeff FG. Serotonergic systems. Psychiatr Clin N Am, 20: 723-39, 1997.
36. Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron, 28: 343-7, 2000.
37. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet, 73: 370-6, 2003.
38. Han L, Nielsen DA, Rosenthal NE, Jefferson K, Kaye W, Murphy D, et al. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervuos, and alcoholism. Biol Psychiatry, 45: 615-9, 1999.
39. Hasler G, Kazuba D, Murphy DL. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am J Med Genet B Neuropsychiatr Genet, 141: 403-8, 2006.
40. Hemmings SM, Kinnear CJ, Lochner C, Niehaus DJ, Knowles JA, Moolman-Smook JC, et al. Early versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatry Res, 128: 175-82, 2004.
41. Hemmings SM, Kinnear CJ, Niehaus DJ, Moolman-Smook JC, Lochner C, Knowles JA, et al. Investigating the rale of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur Neuropsychoph, 13: 93-8, 2003.
42. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet, 78: 815-26, 2006.
43. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA, 94: 4572-5, 1997.
44. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry, 45: 1178-89, 1999.
45. Kim SJ, Lee HS, Kim CH. Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology, 52: 176-82, 2005.
46. Kinnear CJ, Niehaus DJ, Moolman-Smook JC, du Toit PL, van Kradenberg J, Weyers JB, et al. Obsessive-compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int J Neuropsychopharmacol, 3: 327-31, 2000.
47. Kinnear CJ, Niehaus DJ, Seedat S, Moolman-Smook JC, Corfield VA, Malherbe G, et al. Obsessive-compulsive disorder and a novel polymorphism adjacent to the oestrogen response element (ERE 6) upstream from the COMT gene. Psychiatr Genet, 11: 85-7, 2001.
48. Lenane MC, Swedo SE, Leonard H, Pauls DL, Sceery W, Rapoport J. Psychiatric disorders in first-degree relatives of children and adolescent with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry, 29: 407-12, 1990.
49. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Perri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274: 1527-30,1996.
50. Levitan RD, Kaplan AS, Masellis M, Basile VS, Richter MA, Kennedy JL. The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa. Eur Neuropsychoph, 16:1-6, 2006.
51. Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA, et al. Corrigendum to "gender in obsessive-compulsive disorder: clinical and genetic findings". Eur Neuropsychoph, 14:437-45, 2004.
52. McDougle CJ, Epperson CN, Price LH, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry, 3:270-3, 1998.
53. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet, 77: 582-95, 2005.
54. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. Association analysis of the catechol-O-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav, 3: 75-9, 2004.
55. Millet B, Chabane N, Delorme R, Leboyer M, Leroy S, Poirier MF, et al. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet, 116: 55-9, 2003.
56. Mossner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol, 7: 1-6, 2005.
57. Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL. Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am J Psychiatry, 157: 1160-1, 2000.
58. Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, et al. 5HT1Dbeta Receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol Psychiatry, 7: 805-9, 2002.
59. Nestadt G, Samuels J, Riddle M, Bienvenu J, Liang KY, LaBuda M, et al. Afamily study of obsessive-compulsive disorder. Arch Gen Psychiatry, 57: 358-63, 2000.
60. Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N, et al. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry, 1: 461-5, 1996.
61. Nicolini H, Cruz C, Paez F, Camarena B. Dopamine D2 and D4 receptor genes distinguish the clinical presence of tics in obsessive-compulsive disorder. Gac Med Mex, 134: 521-7, 1998.
62. Nicolini H, Hanna G, Baxter L, Schwartz J, Weissbacker K, Spence MA. Segregation analysis of obsessive-compulsive and related disorders: preliminary results. Ursus Med, 1: 25-8, 1991.
63. Niehaus DJ, Kinnear CJ, Corfield VA, du Toit PL, van Kradenburg J, Moolman-Smook JC, et al. Association between a catechol-O-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord, 65: 61-5, 2001.
64. Novelli E, Nobile M, Diaferia G, Sciuto G, Catalano M. A molecular investigation suggests no relationship between obsessive-compulsive disorder and the dopamine D2 receptor. Neuropsychobiology, 29: 61-3, 1994.
65. Pauls DL, Raymond CL, Robertson MM. The genetics of obsessive-compulsive disorder. In: Zohar Y, Insel T, Rasmussen S, editors. Psychobiological aspects of OCD. Springer, p. 89-100, New York, 1991.
66. Pauls DL, Alsobrook II JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry, 152: 76-84, 1995.
67. Pauls DL, Alsobrook II JP. The inheritance of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am, 8: 481-96, 1999.
68. Poyurovsky M, Michaelovsky E, Frisch A, Knoll G, Amir I, Finkel B, et al. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neurosci Lett, 389: 21-4, 2005.
69. Rapoport J. The neurobiology of obsessive-compulsive disorder. JAMA, 260: 2888, 1988.
70. Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet, 96: 721-4, 2000.
71. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, et al. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry, 11: 763-70, 2006.
72. Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis os attention-deficit and hyperactivity. Br J Psychiatry, 174: 105-11, 1999.
73. Tot S, Erdal ME, Yazici K, Yazici AE, Metin O. T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder. Eur Psychiatry, 18: 249-54, 2003.
74. Urraca N, Camarena B, Gomez-Caudillo L, Esmer MC, Nicolini H. Mu opioid receptor gene as a candidate for the study of obsessive-compulsive disorder with and without tics. Am J Med Genet B Neuropsychiatr Genet, 127(1): 94-6, 2004.
75. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet, 8: 450-8, 2005.
76. Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G, et al. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry, 7: 1054-7, 2002.
77. Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N, et al. Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm, 111: 817-25, 2004.
78. Zai G, Arnold P, Burroughs E, Barr CL, Richter MA, Kennedy JL. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet, 134: 25-9, 2005.
79. Zohar J, Zohar-Kadouch RC, Kindler S. Current concepts in the pharmacological treatment of obsessive-compulsive disorder. Drugs, 43: 210-8, 1992.
80. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry, 45: 167-72, 1988.